Catalyst Pharmaceuticals (CPRX) News Today $20.34 -0.19 (-0.93%) As of 11:42 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CPRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Aberdeen Group plc Sells 76,534 Shares of Catalyst Pharmaceuticals, Inc. $CPRXOctober 15 at 3:42 AM | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Upgraded to "Buy" at Wall Street ZenOctober 12, 2025 | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Earns "Hold (C+)" Rating from Weiss RatingsOctober 9, 2025 | marketbeat.comCatalyst Pharmaceuticals Announces Presentations at Upcoming Scientific ConferencesOctober 9, 2025 | globenewswire.comWhat do Analysts Think About Catalyst Pharmaceuticals (CPRX)?October 8, 2025 | finance.yahoo.comAssessing Catalyst Pharmaceuticals (CPRX) Valuation After $200 Million Share Buyback AnnouncementOctober 6, 2025 | finance.yahoo.comCatalyst Pharma Announces $200M Share Repurchase ProgramOctober 4, 2025 | theglobeandmail.comWall Street Zen Downgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) to HoldOctober 4, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives Consensus Rating of "Buy" from AnalystsOctober 3, 2025 | marketbeat.comCatalyst Pharmaceuticals announces $200M share repurchase programOctober 1, 2025 | msn.comCatalyst Pharmaceuticals announces $200M share repurchase program through 2026October 1, 2025 | msn.comShare Repurchase Plan Announced by Catalyst Pharmaceuticals (NASDAQ:CPRX) Board of Directors October 1, 2025 | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Trading Up 9.5% - What's Next?October 1, 2025 | marketbeat.comCatalyst Pharmaceuticals Announces $200 Million Share Repurchase ProgramOctober 1, 2025 | globenewswire.comCatalyst Pharmaceuticals Rings the Closing BellSeptember 30, 2025 | nasdaq.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Sets New 1-Year Low - Time to Sell?September 25, 2025 | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Upgraded to Buy at Wall Street ZenSeptember 21, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. $CPRX Stock Holdings Boosted by Redhawk Wealth Advisors Inc.September 19, 2025 | marketbeat.comStrs Ohio Takes Position in Catalyst Pharmaceuticals, Inc. $CPRXSeptember 19, 2025 | marketbeat.comWesbanco Bank Inc. Has $1.22 Million Stock Position in Catalyst Pharmaceuticals, Inc. $CPRXSeptember 17, 2025 | marketbeat.comRichard P Slaughter Associates Inc Sells 54,614 Shares of Catalyst Pharmaceuticals, Inc. $CPRXSeptember 16, 2025 | marketbeat.comSwedbank AB Invests $14.94 Million in Catalyst Pharmaceuticals, Inc. $CPRXSeptember 16, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. $CPRX Shares Sold by Woodline Partners LPSeptember 15, 2025 | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Lowered to Hold Rating by Wall Street ZenSeptember 15, 2025 | marketbeat.comAQR Capital Management LLC Decreases Position in Catalyst Pharmaceuticals, Inc. $CPRXSeptember 13, 2025 | marketbeat.comBank of America Securities Sticks to Their Buy Rating for Catalyst Pharma (CPRX)September 12, 2025 | theglobeandmail.comInsider Selling: Catalyst Pharmaceuticals (NASDAQ:CPRX) Insider Sells 30,000 Shares of StockSeptember 12, 2025 | marketbeat.comFred Alger Management LLC Invests $1.25 Million in Catalyst Pharmaceuticals, Inc. $CPRXSeptember 12, 2025 | marketbeat.comBrian Elsbernd Sells 30,000 Shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) StockSeptember 11, 2025 | insidertrades.comJacobs Levy Equity Management Inc. Sells 406,554 Shares of Catalyst Pharmaceuticals, Inc. $CPRXSeptember 9, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Rating of "Buy" by AnalystsSeptember 9, 2025 | marketbeat.comAdvisors Asset Management Inc. Increases Stock Holdings in Catalyst Pharmaceuticals, Inc. $CPRXSeptember 8, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. $CPRX Shares Bought by New Vernon Capital Holdings II LLCSeptember 7, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. $CPRX Shares Bought by Clark Capital Management Group Inc.September 7, 2025 | marketbeat.comNomura Holdings Inc. Makes New Investment in Catalyst Pharmaceuticals, Inc. $CPRXSeptember 7, 2025 | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Insider Brian Elsbernd Sells 20,000 SharesSeptember 6, 2025 | insidertrades.comState of Wyoming Sells 12,771 Shares of Catalyst Pharmaceuticals, Inc. $CPRXSeptember 4, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. $CPRX Shares Acquired by Trexquant Investment LPSeptember 3, 2025 | marketbeat.comRafferty Asset Management LLC Sells 12,393 Shares of Catalyst Pharmaceuticals, Inc. $CPRXSeptember 2, 2025 | marketbeat.comAlphaQuest LLC Sells 35,327 Shares of Catalyst Pharmaceuticals, Inc. $CPRXSeptember 2, 2025 | marketbeat.comRaymond James Financial Inc. Has $10.68 Million Position in Catalyst Pharmaceuticals, Inc. $CPRXSeptember 2, 2025 | marketbeat.comNorthern Trust Corp Has $36.04 Million Holdings in Catalyst Pharmaceuticals, Inc. $CPRXSeptember 1, 2025 | marketbeat.comCatalyst Pharmaceuticals President and CEO Trades $473K In Company StockAugust 29, 2025 | benzinga.comDirector At Catalyst Pharmaceuticals Sells $525K Of StockAugust 29, 2025 | benzinga.comInsider Selling: Catalyst Pharmaceuticals (NASDAQ:CPRX) CEO Sells 22,970 Shares of StockAugust 29, 2025 | insidertrades.comCatalyst Pharmaceuticals, Inc. (CPRX) Secures FIRDAPSE Market Exclusivity Until 2035August 29, 2025 | uk.finance.yahoo.comCatalyst Pharmaceuticals to Participate in Upcoming Investor ConferencesAugust 28, 2025 | globenewswire.comCapital Fund Management S.A. Sells 51,122 Shares of Catalyst Pharmaceuticals, Inc. $CPRXAugust 28, 2025 | marketbeat.comCresset Asset Management LLC Takes Position in Catalyst Pharmaceuticals, Inc. $CPRXAugust 28, 2025 | marketbeat.comAmerican Century Companies Inc. Has $12.77 Million Stock Position in Catalyst Pharmaceuticals, Inc. $CPRXAugust 28, 2025 | marketbeat.com Get Catalyst Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CPRX Media Mentions By Week CPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPRX News Sentiment▼0.970.68▲Average Medical News Sentiment CPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPRX Articles This Week▼28▲CPRX Articles Average Week Get the Latest News and Ratings for CPRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Catalyst Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ELAN News VRNA News RVMD News RGC News ABVX News MRUS News RNA News CYTK News RYTM News GRFS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CPRX) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalyst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
